HOME > Conference > Detailed Program(2021)
Opening Ceremony / Keynote & Plenary Session
Forum Overview
Date/Time 9.13(Mon) 13:30 - 18:00 Location Grand Ballroom I,II,III (5F)
Overview A New Normal: A Leap towards Newly Found Future of Biopharmaceuticals
With a global paradigm shift in the health-care industry, where people turn more toward preventive measures than treatments, living a “healthy” long life is far more important than living “longer.”
With this flow, biopharmaceuticals take center stage with their key potential in combining biology and advanced technologies to cope with a novel infectious disease and rare incurable disease. Now that we are on this shifting tide, it is imperative to take measures for biopharmaceuticals’ leap toward the newly found future.
At the GBC 2021, world leaders in biopharmaceuticals gather to discuss “What is the current situation that biopharmaceuticals are facing NOW?” “What are we expecting NEXT?” and “What is the future and BEYOND?. In addition, there will be further discussions on the sustainable future and insights on advanced biopharmaceuticals toward the “New Normal” and even the “Next Normal.”
Time Program Speakers Files
Keynote Speech : A New Normal: A Leap towards Newly Found Future of Biopharmaceuticals
14:00~14:15 15’ Peter Doherty
(Peter Doherty Institute at the University of Melbourne)
14:15~14:55 40’ [Plenary] Preparedness and response against new pandemic in future Jong-koo Lee
(Seoul National University, College of Medicine/Hospital)
14:55~15:35 40’ Robert S. Kerbel
(Sunnybrook Research Institute)
15:35~15:55 20’ Margaret Hamburg
(Fomer FDA commisioner /Nuclear Threat Initiative)
15:55~16:35 40’ Aaron Ciechanover
(Faculty of medicine at the Technion - Israel Institute of Technology)
16:35~17:00 25’ Rogério Gaspar
17:00~17:20 20’ Larry W. Kwak
(City of Hope Comprehensive Cancer Center)
17:20~18:00 40’ The public private partnerships utilized in the US Government program for COVID vaccine development Lawrence Corey
(Fred Hutchinson Cancer Research Center)